Literature DB >> 15044022

The crystal structure of the Escherichia coli lipocalin Blc suggests a possible role in phospholipid binding.

Valérie Campanacci1, Didier Nurizzo, Silvia Spinelli, Christel Valencia, Mariella Tegoni, Christian Cambillau.   

Abstract

Lipocalins form a large multifunctional family of small proteins (15-25 kDa) first discovered in eukaryotes. More recently, several types of bacterial lipocalins have been reported, among which Blc from Escherichia coli is an outer membrane lipoprotein. As part of our structural genomics effort on proteins from E. coli, we have expressed, crystallized and solved the structure of Blc at 1.8 A resolution using remote SAD with xenon. The structure of Blc, the first of a bacterial lipocalin, exhibits a classical fold formed by a beta-barrel and a alpha-helix similar to that of the moth bilin binding protein. Its empty and open cavity, however, is too narrow to accommodate bilin, while the alkyl chains of two fatty acids or of a phospholipid could be readily modeled inside the cavity. Blc was reported to be expressed under stress conditions such as starvation or high osmolarity, during which the cell envelope suffers and requires maintenance. These data, together with our structural interpretation, suggest a role for Blc in storage or transport of lipids necessary for membrane repair or maintenance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044022     DOI: 10.1016/S0014-5793(04)00199-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  A hydrocarbon ruler measures palmitate in the enzymatic acylation of endotoxin.

Authors:  Victoria E Ahn; Eileen I Lo; Christian K Engel; Lu Chen; Peter M Hwang; Lewis E Kay; Russell E Bishop; Gilbert G Privé
Journal:  EMBO J       Date:  2004-07-22       Impact factor: 11.598

2.  Point mutational analysis of the liganding site in human glycolipid transfer protein. Functionality of the complex.

Authors:  Margarita L Malakhova; Lucy Malinina; Helen M Pike; Alexander T Kanack; Dinshaw J Patel; Rhoderick E Brown
Journal:  J Biol Chem       Date:  2005-05-18       Impact factor: 5.157

3.  The membrane bound bacterial lipocalin Blc is a functional dimer with binding preference for lysophospholipids.

Authors:  Valérie Campanacci; Russell E Bishop; Stéphanie Blangy; Mariella Tegoni; Christian Cambillau
Journal:  FEBS Lett       Date:  2006-08-10       Impact factor: 4.124

4.  Compensation of the metabolic costs of antibiotic resistance by physiological adaptation in Escherichia coli.

Authors:  Nadine Händel; J Merijn Schuurmans; Stanley Brul; Benno H ter Kuile
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

5.  Identification and characterization of the lipid-binding property of GrlR, a locus of enterocyte effacement regulator.

Authors:  Chacko Jobichen; Aaron Z Fernandis; Adrian Velazquez-Campoy; Ka Yin Leung; Yu-Keung Mok; Markus R Wenk; J Sivaraman
Journal:  Biochem J       Date:  2009-05-13       Impact factor: 3.857

Review 6.  Tear film lipids.

Authors:  Igor A Butovich
Journal:  Exp Eye Res       Date:  2013-06-12       Impact factor: 3.467

7.  Lipocalin Blc is a potential heme-binding protein.

Authors:  Nina G Bozhanova; M Wade Calcutt; William N Beavers; Benjamin P Brown; Eric P Skaar; Jens Meiler
Journal:  FEBS Lett       Date:  2020-12-03       Impact factor: 4.124

8.  Origin and evolution of protein fold designs inferred from phylogenomic analysis of CATH domain structures in proteomes.

Authors:  Syed Abbas Bukhari; Gustavo Caetano-Anollés
Journal:  PLoS Comput Biol       Date:  2013-03-28       Impact factor: 4.475

9.  Distantly related lipocalins share two conserved clusters of hydrophobic residues: use in homology modeling.

Authors:  Benoit Adam; Benoit Charloteaux; Jerome Beaufays; Luc Vanhamme; Edmond Godfroid; Robert Brasseur; Laurence Lins
Journal:  BMC Struct Biol       Date:  2008-01-11

10.  XFEL and NMR Structures of Francisella Lipoprotein Reveal Conformational Space of Drug Target against Tularemia.

Authors:  James Zook; Mrinal Shekhar; Debra Hansen; Chelsie Conrad; Thomas Grant; Chitrak Gupta; Thomas White; Anton Barty; Shibom Basu; Yun Zhao; Nadia Zatsepin; Andrii Ishchenko; Alex Batyuk; Cornelius Gati; Chufeng Li; Lorenzo Galli; Jesse Coe; Mark Hunter; Meng Liang; Uwe Weierstall; Garret Nelson; Daniel James; Benjamin Stauch; Felicia Craciunescu; Darren Thifault; Wei Liu; Vadim Cherezov; Abhishek Singharoy; Petra Fromme
Journal:  Structure       Date:  2020-03-05       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.